NECLIFENSENECTAR LIFESCIENCES LTD.· PharmaceuticalsLowNeutral
Announced Sat, 19 Sept · 11:53 IST

Revised 31st AGM proceedings filed after cut-off date error

Board & Shareholder Meetings View source PDFExplain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹11.00
prior close
₹10.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+1.3+1.3+1.5
Up moveDown movePending
AI summary

Nectar Lifesciences filed revised proceedings of its 31st AGM held on Sept 18, 2026 via video conferencing after correcting an inadvertent error in the cut-off date (Sept 11, 2026). Members transacted items including adoption of FY26 standalone and consolidated financial statements, re-appointment of CMD Sanjiv Goyal by rotation, re-appointment of two independent directors for a second five-year term, and appointment of a new non-executive director. Both auditors gave unqualified opinions.

Likely market impact

Routine procedural correction with no material effect on operations or shareholder value; voting results awaited.